Valuation: Senzime AB

Market Cap 527M 53.31M 47.81M 43.69M 39.89M 75.15M 5.01B 77.52M 210M 2.67B 200M 196M 8.44B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 527M 53.31M 47.81M 43.69M 39.89M 75.15M 5.01B 77.52M 210M 2.67B 200M 196M 8.44B EV / Sales 2026 *
4.58x
EV / Sales 2027 * 2.85x
Free-Float
40.74%
Yield 2026 *
-
Yield 2027 * -
1 day+2.92%
1 week-1.03%
Current month-1.03%
1 month+6.01%
3 months-14.21%
6 months-26.94%
Current year-37.96%
1 week 3.08
Extreme 3.085
3.64
1 month 2.61
Extreme 2.61
3.66
Current year 2.35
Extreme 2.35
6
1 year 2.35
Extreme 2.35
6
3 years 2.35
Extreme 2.35
9.6
5 years 2.35
Extreme 2.35
24.8
10 years 2.35
Extreme 2.35
28.5
Manager TitleAgeSince
Chief Executive Officer 53 03/05/2023
Director of Finance/CFO 56 01/01/2022
Chief Tech/Sci/R&D Officer 50 01/01/2023
Director TitleAgeSince
Chairman 53 03/05/2023
Director/Board Member 70 01/01/2016
Director/Board Member 63 05/03/2020
Date Insider Type Main position Quantity % Market Cap. Importance
28/09/26 Buy

Director

178,388 0.1135%
25/09/26 Buy

Chief Technology Officer

30,000 0.0191%
24/09/26 Buy

Chief Technology Officer

30,000 0.0191%
Change 5-day change 1-year change 3-year change Capi.($)
+2.92%-1.03%-39.31%-46.40% 52.26M
-3.23%+3.51%-12.02%+15.72% 197B
-2.90%+5.45%+13.04%+38.65% 128B
-2.75%+11.65%-7.90%+17.71% 128B
+0.96%+5.15%-38.02%+12.24% 99B
-1.80%+0.82%-7.41%+69.42% 64.82B
-0.78%+7.07%+19.44%-18.22% 58.17B
+0.79%+22.65%-5.28%+59.81% 52.84B
-6.98%-14.56%-12.60%+42.69% 50.69B
-2.36%+3.72%+3.27%-8.07% 37.23B
Average -1.61%+5.82%-8.68%+18.36% 81.55B
Weighted average by Cap. -2.24%+6.12%-6.88%+24.51%

Financials

2026 *2027 *
Net sales 115M 11.63M 10.43M 9.53M 8.7M 16.39M 1.09B 16.91M 45.82M 583M 43.65M 42.71M 1.84B 185M 18.7M 16.78M 15.33M 14M 26.37M 1.76B 27.2M 73.69M 938M 70.21M 68.7M 2.96B
Net income -67.1M -6.79M -6.09M -5.57M -5.08M -9.57M -638M -9.88M -26.76M -341M -25.49M -24.94M -1.08B -36.5M -3.69M -3.31M -3.03M -2.76M -5.21M -347M -5.37M -14.55M -185M -13.87M -13.57M -585M
Net Debt - -
Projected Income Statement - Annual - Senzime AB
Logo Senzime AB
Senzime AB (publ.) is a Sweden-based company engaged in the development, manufacture and marketing of biosensors for measuring metabolites in biological fluids, such as human blood and cell culture substrates for the pharmaceutical and healthcare segments. The Company focuses on the following application areas: medical diagnostic instruments, pharmaceutical industry, chemical processing, and food and beverage processing. As of December 31, 2011, the Company marketed three products, namely SENZ-100G, for continuous analysis of glucose in the fermentation solutions; SENZ-100L, for continuous analysis of lactate in fermentation solutions, and SENZ-200G, for continuous analysis of glucose in blood during intensive care.
Employees
59
Date Price Change Volume
06/11/26 SEK 3.350 +2.92% 257,759
05/11/26 SEK 3.255 +0.15% 512,028
04/11/26 SEK 3.250 +3.83% 549,929
03/11/26 SEK 3.130 -4.72% 453,080
02/11/26 SEK 3.285 -2.95% 688,211

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Senzime AB
  1. Stock Market
  2. Stocks
  3. SEZI Stock